This inventor holds 3 USPTO granted patents. Top assignees: Glaxo Group Limited, Glaxosmithkline Intellectual Property Development Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,170 
1 out of 242 
Years Active: 2015
Title: The Innovative Contributions of Yu Xue
Introduction
Yu Xue, an accomplished inventor based in King of Prussia, Pennsylvania, has made significant strides in the field of biotechnology. With a total of three patents to his name, Xue has focused his efforts on developing antigen binding proteins that target critical receptors in humans, particularly those associated with various diseases and cancers.
Latest Patents
Among Yu Xue's notable patents are innovations related to CD127 binding proteins. These antigen binding proteins specifically bind to the human IL-7 receptor (CD127) and are primarily useful in the treatment of autoimmune diseases, including multiple sclerosis. Furthermore, he has developed additional antigen binding proteins that target HER3. This innovation includes polynucleotides encoding such proteins and pharmaceutical compositions that utilize these antibodies. Notably, these advancements hold promise in the treatment or prophylaxis of numerous cancers such as breast, ovarian, prostate, bladder, pancreatic, gastric, melanoma, and other cancers that overexpress the HER3 receptor.
Career Highlights
Xue has a distinguished career, having worked with leading companies in the pharmaceutical industry, including Glaxo Group Limited and GlaxoSmithKline Intellectual Property Development Limited. His work in these organizations has significantly contributed to the advancement of medical therapies and innovations in the market.
Collaborations
Throughout his career, Yu Xue has collaborated with esteemed colleagues such as Ian Kirby and Thomas Matthew Webb. These partnerships have been instrumental in fostering innovation and pushing the boundaries of current research.
Conclusion
Yu Xue's contributions to the field of biotechnology through his patents and collaborations demonstrate his commitment to addressing critical health challenges. His work not only advances scientific knowledge but also offers potential therapeutic solutions for patients suffering from autoimmune diseases and various forms of cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile